The sudden wave of pregnancies among those on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has surprised patients and doctors alike
But looking closer at the numbers, that risk went from 1 in 1,000 people to 2 in 1,000 people, Garg says
Additionally, there is no peer-reviewed data on whether these drugs cause bad breath or why they might
Drug shortages during the study period may also have influenced treatment patterns
Does the 30-day window apply to every compounded prescription
Most studies done in Cameroon focused on the detection of the presence of mycotoxins in foods [9,11,47,63,64] and human biomonitoring analysis on body fluids [14,22,44]